明泰医疗有限公司
请输入包含最少两个字元或数字的关键字。
FeNO Device TM2120
美元 $4600.00 - 美元 $4800.00
适用年龄:
12-18个月, 婴幼儿, 长者, 儿童, 成人, 0-3个月, 18-24个月, 9-12个月, 6-9个月, 3-6个月, 幼童, 大童
品牌:
SUNVOU
认证:
ISO 13485, US Patent, CE IVD
颜色:
White
性别:
男女通用
型号编号:
TM2120
电源类型:
干充两用
尺寸:
195*145*80mm
重量:
1.0kg
描述
证书及文件
联络供应商
描述
FeNO 1+2 is a system that detects, quantifies, and monitors airway inflammation. It's response to pharmacological treatment, therapy, screening, and assessment of Primary Ciliary Dyskinesias (PCD) and accurate measurements of Exhaled Nitric Oxide (NO), bronchial, nasal, and alveolar for early detection and patient management of asthma and inflammation.
- Meets all ERS/ATS /CE-IVD guidelines, standardized tests
- Easy software-driven testing procedure
- Simple, fast, non-invasive measurement with quality control
- Lowest cost per test
- User-accessible NO sensor, long-lasting, typically 24 months or longer.
- Can connect to HIS system
3 TESTING MODES:
- Bronchial - FeNO 50 at a flow rate of 50ml/s with incentive screen.
- Alveolar - FeNO 200/CaNO with automatic Calv and Jaw graphic generation, at different flow rates of 200ml/s
- Nasal - FnNO 5 at a sample flow rate of 10ml/s through a nasal catheter, breathing through resistance for velum closing.
with features Online, Offline, and Tidal modes, allowing for flexible monitoring and assessment of adult, child , and baby
The device can do a "Joint examination of large and small airways and upper and lower airways" 1+2 in one device, and monitor various respiratory diseases, including but not only:
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Chronic Cough
- Allergic Rhinitis
- Primary Ciliary Dyskinesia (PCD)
证书及文件
证书名称
发行机构
证书类型
有效日期
US Patent
发行机构
United States Patent
证书类型
Patent
有效日期
2018年05月15日
-
(不適用)
CE IVD
发行机构
JOYSUN GROUP
证书类型
Others
有效日期
2024年08月13日
-
2025年08月12日
您或许喜欢
确定要取消关注此供应商?